Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Feb 26;40(Suppl 1):119. doi: 10.1007/s40273-022-01138-6

Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)

Noman Paracha 1, Pollyanna Hudson 2, Stephen Mitchell 2, C Simone Sutherland 1,✉
PMCID: PMC8994722  PMID: 35217993

Correction to: PharmacoEconomics (2021) 10.1007/s40273-021-01095-6

In Table 1 of this article, the data in the 8th column of the intervention price row was incorrectly published as

OA: list price $2,125,000

Nus: NR

It should have been

OA: NR

Nus: list price of SEK 800,757 per vial (€78,300)

Articles from Pharmacoeconomics are provided here courtesy of Springer

RESOURCES